(HSGX) |
0 (0%) 04-20 12:16 |
Open: | |
High: | |
Low: | |
Volume: | 0 |
Market Cap: | 0(M) |
PE Ratio: | 0 |
Exchange: | |
Industry: | |
Sector: |
Technical analysis | ||||
sell | buy |
Resistance 2: | |
Resistance 1: | |
Pivot price: | |
Support 1: | |
Support 2: | |
52w High: | |
52w Low: |
EPS | |
Book Value | |
PEG Ratio | |
Gross Profit |
Profit Margin (%) | |
Operating Margin (%) | |
Return on Assets (ttm) | |
Return on Equity (ttm) |
Mon, 30 Sep 2019
Ocugen Announces Completion of its Merger with Histogenics to Create Nasdaq-Listed Clinical-Stage Company ... - Business Wire
Wed, 05 Sep 2018
Histogenics plunges on missed endpoint in NeoCart trial - Mass Device
Thu, 11 Aug 2016
Histogenics (HSGX) Stock Price, News & Analysis - MarketBeat
Mon, 17 Nov 2014
Histogenics sets range for $60m IPO - Mass Device
Sat, 20 Apr 2024
Sat, 20 Apr 2024
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |